Sigma Planning Corp - CUE BIOPHARMA INC ownership

CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 38 filers reported holding CUE BIOPHARMA INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Sigma Planning Corp ownership history of CUE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$562,822
-31.6%
244,705
+8.6%
0.02%
-30.0%
Q2 2023$822,345
+4.3%
225,300
+2.0%
0.03%
+15.4%
Q1 2023$788,574
+43.6%
220,889
+14.6%
0.03%
+30.0%
Q4 2022$549,292
+30.8%
192,734
+2.3%
0.02%
+25.0%
Q3 2022$420,000
+1.0%
188,424
+12.8%
0.02%
+14.3%
Q2 2022$416,000
-34.3%
167,106
+28.8%
0.01%
-26.3%
Q1 2022$633,000
-34.8%
129,728
+51.0%
0.02%
-29.6%
Q4 2021$971,000
-20.9%
85,893
+2.0%
0.03%
-27.0%
Q3 2021$1,227,000
+28.9%
84,243
+3.1%
0.04%
+32.1%
Q2 2021$952,000
+6.7%
81,701
+11.8%
0.03%0.0%
Q1 2021$892,000
-0.3%
73,088
+2.1%
0.03%
-6.7%
Q4 2020$895,000
-0.6%
71,576
+19.6%
0.03%
-16.7%
Q3 2020$900,000
-30.8%
59,823
+12.7%
0.04%
-36.8%
Q2 2020$1,301,000
+38.4%
53,079
-19.9%
0.06%
+1.8%
Q1 2020$940,000
-9.4%
66,245
+1.4%
0.06%
+27.3%
Q4 2019$1,038,000
+104.3%
65,360
+8.6%
0.04%
+83.3%
Q3 2019$508,000
+18.1%
60,210
+25.9%
0.02%
+9.1%
Q2 2019$430,000
+32.3%
47,805
+13.6%
0.02%
+22.2%
Q1 2019$325,00042,0990.02%
Other shareholders
CUE BIOPHARMA INC shareholders Q2 2019
NameSharesValueWeighting ↓
Corriente Advisors, LLC 1,437,445$21,634,00010.97%
Prosight Management, LP 709,936$10,685,0005.08%
Voss Capital, LLC 226,573$3,410,0001.94%
Robertson Stephens Wealth Management, LLC 484,000$7,284,0001.79%
Slate Path Capital LP 1,483,619$22,328,0001.27%
Nantahala Capital Management 2,342,216$35,250,0001.08%
SANDERS MORRIS HARRIS LLC 142,430$2,312,0000.63%
Rock Creek Group, LP 80,000$1,204,0000.62%
PRECEPT MANAGEMENT LLC 150,000$2,258,0000.55%
PA Capital LLC 46,850$705,0000.50%
View complete list of CUE BIOPHARMA INC shareholders